On April 27, 2026, Vietnam’s Ministry of Industry and Trade (MOIT) updated its Guidelines for Import Management of Medical Auxiliary Equipment, effective June 1, 2026. The revision exempts infant monitors—including video, audio, respiration, and temperature monitoring devices—from mandatory local type testing upon import. However, importers must submit a valid Chinese NMPA Class II medical device filing certificate (bilingual Chinese–English version). This change directly affects exporters and importers of nursery furniture and infant monitoring equipment in China–Vietnam trade channels.

Event Overview

The Ministry of Industry and Trade of Vietnam (MOIT) issued an update to the Guidelines for Import Management of Medical Auxiliary Equipment on April 27, 2026. Starting June 1, 2026, infant monitors—defined as devices for video, audio, respiration, or temperature monitoring of infants—are no longer subject to compulsory local type testing during registration. Instead, importers must provide a valid Class II medical device filing certificate issued by China’s National Medical Products Administration (NMPA), in both Chinese and English. The policy applies exclusively to this product category under the revised guidelines.

Industries Affected

Direct Exporters & Importers

Companies exporting infant monitors from China to Vietnam will experience reduced technical compliance lead time, as local type testing—a historically time- and resource-intensive step—is now waived. However, reliance on NMPA Class II filing introduces a new dependency: only products already registered under China’s Class II framework qualify. Firms without such filings cannot leverage this exemption, regardless of device functionality or conformity with Vietnamese standards.

Contract Manufacturers & OEMs

OEM/ODM manufacturers producing infant monitors for Chinese export brands must ensure their client-facing documentation aligns with NMPA Class II requirements—including technical files, risk management reports, and labeling in Chinese. Any deviation may prevent downstream importers from meeting the MOIT requirement, even if the physical product remains unchanged.

Distribution & Channel Operators

Vietnamese distributors and authorized representatives handling infant monitors must verify the authenticity and validity of submitted NMPA Class II certificates prior to registration submission. Unlike previous MOIT procedures, the absence of local testing shifts verification responsibility upstream—to document accuracy, bilingual consistency, and regulatory alignment between China’s filing scope and Vietnam’s intended use classification.

Regulatory & Compliance Service Providers

Third-party regulatory consultants supporting China–Vietnam medical device trade must now integrate NMPA filing validation into pre-submission checks. This includes confirming that the NMPA certificate explicitly covers the exact model(s) being imported, and that its “intended use” statement matches MOIT’s definition of infant monitor functions (e.g., respiration or temperature monitoring).

What Stakeholders Should Focus On Now

Monitor official MOIT implementation notices and interpretation guidance

While the exemption takes effect June 1, 2026, MOIT has not yet published detailed instructions on certificate format, translation requirements beyond bilingual presentation, or acceptance criteria for NMPA filing scope alignment. Stakeholders should track MOIT’s official portal and Vietnam’s National Agency for Technical Regulation (NATR) for clarifications ahead of first submissions.

Verify NMPA Class II filing status before initiating Vietnam registration

Importers must confirm that each infant monitor model has an active, non-expired NMPA Class II filing—and that the filing explicitly includes functions cited in MOIT’s definition (e.g., “infant respiration monitoring”). Relying solely on general “medical electronic device” classifications is insufficient; functional specificity matters.

Distinguish between policy signal and operational readiness

This update signals MOIT’s intent to harmonize certain regulatory steps with China’s existing oversight—but it does not replace other Vietnam-specific requirements (e.g., labeling in Vietnamese, local authorized representative appointment, or post-market surveillance obligations). Companies should treat the exemption as one streamlined step within a broader, unchanged registration workflow.

Prepare bilingual NMPA certificate packages and internal alignment

Exporters and importers should compile complete NMPA filing dossiers—including original Chinese documents, certified English translations, and evidence of current validity (e.g., screenshot of NMPA public database entry). Internal teams (regulatory, logistics, sales) must align on which models qualify and how to communicate eligibility to Vietnamese partners.

Editorial Perspective / Industry Observation

Observably, this measure is less a full regulatory convergence and more a pragmatic administrative alignment—targeting a high-volume, low-risk device category where China’s Class II framework already imposes substantive technical and quality controls. Analysis shows MOIT is selectively leveraging existing foreign assessments rather than outsourcing oversight; the exemption applies only to infant monitors, not broader categories of medical auxiliary equipment. From an industry perspective, this reflects growing recognition of China’s evolving medical device regulatory infrastructure—but also highlights continued fragmentation: NMPA filing remains a prerequisite, not a substitute, for Vietnam’s market access process. Current developments suggest MOIT is testing interoperability on narrowly defined products before considering wider application.

Concluding, this policy adjustment shortens one specific procedural step for a defined product group but does not reduce overall regulatory diligence. It is best understood not as deregulation, but as a targeted efficiency measure contingent on prior compliance in another jurisdiction. Stakeholders should view it as an opportunity to accelerate time-to-market—provided foundational documentation is already in place.

Source: Ministry of Industry and Trade of Vietnam (MOIT), Guidelines for Import Management of Medical Auxiliary Equipment, updated April 27, 2026; effective June 1, 2026. Note: Implementation details—including certificate validation protocols and scope interpretation—are pending further MOIT or NATR guidance and remain under observation.